Patents by Inventor Dana Davis

Dana Davis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240079106
    Abstract: A method includes receiving data representing graphomotor motion during a succession of executions of graphomotor diagnostic tasks performed in a medical context by a subject, processing the received data using a computer, including determining a first set of quantitative features from a first execution of a task by the subject, and determining a second set of quantitative features from a second execution of a task by the subject, determining one or more metrics based on a comparison to the successive executions, including using at least the first set of quantitative features and the second set of quantitative features to determine said metrics, and providing a diagnostic report associated with neurocognitive mechanisms underlying the subject's execution of the tasks based on the determined metrics.
    Type: Application
    Filed: November 9, 2023
    Publication date: March 7, 2024
    Applicants: MASSACHUSETTS INSTITUTE OF TECHNOLOGY, LAHEY CLINIC FOUNDATION, INC.
    Inventors: Randall Davis, Dana L. Penney
  • Publication number: 20230002324
    Abstract: Disclosed herein are naphthoquinone derivative compounds of the formula shown below, compositions thereof, and methods of using such compounds and compositions for treating or suppressing oxidative stress disorders and/or neurodegenerative disorders and/or for inhibiting ferroptosis.
    Type: Application
    Filed: June 13, 2020
    Publication date: January 5, 2023
    Inventors: Maulen M. UTEULIYEV, Lianhe SHU, Steven J. RICHARDS, Alexander A. WARKENTIN, Dana DAVIS
  • Publication number: 20220257533
    Abstract: Compounds, compositions, and methods for treatment of, or prophylaxis against, inflammation and/or oxidative stress are disclosed.
    Type: Application
    Filed: November 29, 2021
    Publication date: August 18, 2022
    Inventors: Guy M. MILLER, Jeffery K. TRIMMER, William SHRADER, Andrew W. HINMAN, Charles R. HOLST, Joey C. LATHAM, Joel J. BRUEGGER, Kevin P. MCCUSKER, Gözde ULAS, Dana DAVIS, Amanda H. KAHN-KIRBY, Edgar P. LEE, Stephanie A. MALONE, Steven J. RICHARDS, Matthew B. KLEIN
  • Publication number: 20220175186
    Abstract: The air fryer with removable heating coil for cleaning is an appliance. The air fryer with removable heating coil for cleaning is an oven. The air fryer with removable heating coil for cleaning is configured for use with a foodstuff. The air fryer with removable heating coil for cleaning incorporates a thermal shell, a cooking pan, and a control circuit. The thermal shell contains the control circuit. The cooking pan inserts into the thermal shell. The foodstuff is contained in the cooking pan. The control circuit is an electric circuit. The control circuit generates and controls the heat necessary to heat the foodstuff within the cooking pan.
    Type: Application
    Filed: December 8, 2020
    Publication date: June 9, 2022
    Inventor: DANA DAVIS
  • Publication number: 20200121618
    Abstract: Compounds, compositions, and methods for treatment of, or prophylaxis against, inflammation and/or oxidative stress are disclosed.
    Type: Application
    Filed: April 14, 2018
    Publication date: April 23, 2020
    Inventors: Guy M. MILLER, Jeffery K. TRIMMER, William D. SHRADER, Andrew W. HINMAN, Charles R. HOLST, Joey C. LATHAM, Joel J. BRUEGGER, Kevin P. MCCUSKER, Gozde ULAS, Dana DAVIS, Amanda H. KAHN-KIRBY, Edgar P. LEE, Stephanie A. MALONE, Steven J. RICHARDS, Matthew B. KLEIN
  • Patent number: 10470986
    Abstract: Provided herein are methods and compositions comprising resorcinol derivatives for the use of treating, regulating or preventing a skin condition characterized by oxidative stress or a degenerative process. Methods of preventing, lightening or reducing the appearance of visible discontinuities of the skin resulting from skin pigmentation, skin aging, or other disorders are also disclosed.
    Type: Grant
    Filed: March 6, 2014
    Date of Patent: November 12, 2019
    Assignee: Conopco, Inc.
    Inventors: Andrew W Hinman, Dana Davis, Viktoria Kheifets
  • Patent number: 9868711
    Abstract: Disclosed herein are phenazine-3-one and phenothiazine-3-one derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: January 16, 2018
    Assignee: BIOELECTRON TECHNOLOGY CORPORATION
    Inventors: Andrew W. Hinman, Dana Davis, William D. Shrader
  • Patent number: 9670170
    Abstract: Disclosed herein are resorufin derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: June 6, 2017
    Assignee: BIOELECTRON TECHNOLOGY CORPORATION
    Inventors: Andrew W. Hinman, Dana Davis, William D. Shrader
  • Patent number: 9296712
    Abstract: Disclosed herein are resorufin derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: March 29, 2016
    Assignee: Edison Pharmaceuticals, Inc.
    Inventors: Andrew W. Hinman, Dana Davis, William D. Shrader
  • Publication number: 20160039776
    Abstract: Disclosed herein are phenazine-3-one and phenothiazine-3-one derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging.
    Type: Application
    Filed: March 14, 2014
    Publication date: February 11, 2016
    Inventors: Andrew W. HINMAN, Dana DAVIS, William D. SHRADER
  • Publication number: 20160039775
    Abstract: Disclosed herein are resorufin derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging.
    Type: Application
    Filed: March 14, 2014
    Publication date: February 11, 2016
    Inventors: Andrew W. HINMAN, Dana DAVIS, William D. SHRADER
  • Publication number: 20160000669
    Abstract: Provided herein are methods and compositions comprising resorcinol derivatives for the use of treating, regulating or preventing a skin condition characterized by oxidative stress or a degenerative process. Methods of preventing, lightening or reducing the appearance of visible discontinuities of the skin resulting from skin pigmentation, skin aging, or other disorders are also disclosed.
    Type: Application
    Filed: March 6, 2014
    Publication date: January 7, 2016
    Applicant: Conopco, Inc., d/b/a UNILEVER
    Inventors: Andrew W HINMAN, Dana DAVIS, Viktoria KHEIFETS
  • Publication number: 20140275054
    Abstract: Disclosed herein are resorufin derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: Edison Pharmaceuticals, Inc.
    Inventors: Andrew W. HINMAN, Dana Davis, William D. Shrader
  • Publication number: 20140275045
    Abstract: Disclosed herein are phenazine-3-one and phenothiazine-3-one derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: EDISON PHARMACEUTICALS, INC.
    Inventors: Andrew W. HINMAN, Dana Davis, William D. Shrader
  • Publication number: 20140256830
    Abstract: Provided herein are methods and compositions comprising resorcinol derivatives for the use of treating, regulating or preventing a skin condition characterized by oxidative stress or a degenerative process. Methods of preventing, lightening or reducing the appearance of visible discontinuities of the skin resulting from skin pigmentation, skin aging, or other disorders are also disclosed.
    Type: Application
    Filed: March 6, 2014
    Publication date: September 11, 2014
    Inventors: Andrew W. HINMAN, Dana Davis, Viktoria Kheifets
  • Patent number: 7371747
    Abstract: The present invention is directed to novel cyanoalkylamino derivatives that are inhibitors of cysteine protease such as cathepsins K, S, B and L, in particular cathepsin K Pharmaceutical composition comprising these compounds, method of treating diseases mediated by unregulated cysteine protease activity, in particular cathepsin K utilizing these compounds and methods of preparing these compounds are also disclosed.
    Type: Grant
    Filed: November 13, 2002
    Date of Patent: May 13, 2008
    Assignee: Merck Frosst Canada & Co.
    Inventors: Cameron Black, Sheldon N. Crane, Dana Davis, Eduardo L. Setti
  • Patent number: 7223835
    Abstract: A peptide having part or all of the amino acid sequence QKRKRKKSRYKSWSVP (which is part of VEGF) has the ability to inhibit angiogenesis.
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: May 29, 2007
    Assignee: Ark Therapeutics Ltd.
    Inventors: David Selwood, Ian Zachary, Haiyan Jia, Marianne Lohr, Dana Davis
  • Publication number: 20050014941
    Abstract: The present invention is directed to novel cyanoalkylamino derivatives that are inhibitors of cysteine protease such as cathepsins K, S, B and L, in particular cathepsin K Pharmaceutical composition comprising these compounds, method of treating diseases mediated by unregulated cysteine protease activity, in particular cathepsin K utilizing these compounds and methods of preparing these compounds are also disclosed.
    Type: Application
    Filed: November 13, 2002
    Publication date: January 20, 2005
    Inventors: Cameron Black, Sheldon Crane, Dana Davis, Eduardo Setti
  • Publication number: 20040054143
    Abstract: A peptide having part or all of the amino acid sequence QKRKRKKSRYKSWSVP (which is part of VEGF) has the ability to inhibit angiogenesis.
    Type: Application
    Filed: August 6, 2003
    Publication date: March 18, 2004
    Inventors: David Selwood, Ian Zachary, Haiyan Jia, Marianne Lohr, Dana Davis